Aytu BioPharma (NASDAQ:AYTU – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.82) EPS for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.37), Zacks reports. Aytu BioPharma had a negative net margin of 14.60% and a negative return on equity of 31.31%. The company had revenue of $17.98 million for the quarter.
Aytu BioPharma Stock Performance
Aytu BioPharma stock traded down $0.49 during mid-day trading on Friday, reaching $2.36. The company’s stock had a trading volume of 237,675 shares, compared to its average volume of 20,737. The business’s 50 day simple moving average is $2.52 and its 200 day simple moving average is $2.82. The company has a market capitalization of $14.09 million, a price-to-earnings ratio of -0.90 and a beta of -1.43. Aytu BioPharma has a 12 month low of $1.87 and a 12 month high of $3.50.
About Aytu BioPharma
Featured Articles
- Five stocks we like better than Aytu BioPharma
- What are earnings reports?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Best Stocks Under $10.00
- MarketBeat Week in Review – 9/23 – 9/27
- Financial Services Stocks Investing
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.